EXO-CD24 for the treatment of moderate and severe cases of Covid-19?

The request was refused by Department of Health and Social Care.

Dear Department of Health and Social Care,

Is the Department of Health and Social Care or its agencies carrying out trials of the inexpensive medication: EXO-CD24, developed by Israeli Professor Nadir Arber, of Ichilov Integrated Cancer Prevention Center for the treatment of moderate and severe cases of Covid-19?

Yours faithfully,

Roland Gilmore

Department of Health and Social Care

Our ref: DE-1316447
 
Dear Mr Gilmore,
 
Thank you for your correspondence of 21 March about COVID-19 cases. I have
been asked to reply.

The Freedom of Information Act only applies to recorded information such
as paper or electronic archive material.  As your correspondence asked for
general information, rather than requesting recorded information or
documentation, it did not fall under the provisions of the Act.
I apologise I cannot assist directly.

Yours sincerely,
 
Lucy Ogan
Ministerial Correspondence and Public Enquiries
Department of Health and Social Care
 

show quoted sections

FreedomofInformation, Department of Health and Social Care

Dear Mr Gilmore,

Thank you for your further email.

As you are aware, the Freedom of Information Act only applies to recorded information such as paper or electronic archive material. As your correspondence asked for general information rather than requesting recorded information or documentation, it did not fall under the provisions of the Act. It will be answered as general correspondence in due course.

Yours sincerely,

FOI Team
Department of Health and Social Care

show quoted sections